AC Immune’s ACI-7104 Gets FDA Fast Track Designation for Early Parkinson’s Disease

AC Immune’s ACI-7104 receives FDA Fast Track and IND clearance for early Parkinson’s. Phase 2 VacSYn trial can now expand to US sites.